Viewing data from:

MISOPROSTOL

ANDA

MISOPROSTOL | A210201 | ACQ PHARMA LLC

2 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: CYTOTEC(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 4 NDCs

Highest NADAC/Unit

$0.7276

per ea

Lowest NADAC/Unit

$0.7276

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
50268055560MISOPROSTOL 200 MCG TABLET	$0.7276	EA	Generic	—	2026-06-17
43393002404MISOPROSTOL 200 MCG TABLET	$0.7276	EA	Generic	—	2026-06-17
43393020048MISOPROSTOL 200 MCG TABLET	$0.7276	EA	Generic	—	2026-06-17
43393020060MISOPROSTOL 200 MCG TABLET	$0.7276	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain4 active DMFs10 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

EVERLIGHT CHEMICAL INDUSTRIAL CORPMISOPROSTOL

DMF 150172000

EVERLIGHT CHEMICAL INDUSTRIAL CORPMISOPROSTOL - HPMC 1% DISPERSION

DMF 170762003

PIRAMAL HEALTHCARE UK LTDMISOPROSTOL DISPERSION

DMF 211882007

YS LIFE SCIENCE CO LTDMISOPROSTOL HPMC 1% DISPERSION

DMF 230422009

PHARMATECH INTERNATIONAL INCInactiveMISOPROSTOL

DMF 127291997

TEVA PHARMACEUTICAL INDUSTRIES LTDInactiveMISOPROSTOL

DMF 143901999

TEVA PHARMACEUTICAL INDUSTRIES LTDInactiveMISOPROSTOL HPMC DISPERSION 1:100

DMF 143911999

EVERLIGHT CHEMICAL INDUSTRIAL CORPInactiveMISOPROSTOL

DMF 145001999

DAIICHI FINE CHEMICAL CO LTDInactiveMISOPROSTOL DRUG SUBSTANCE

DMF 150442000

DAIICHI FINE CHEMICAL CO LTDInactiveMISOPROSTOL HPMC DISPERSION

DMF 150682000

APOTEX PHARMACHEM INCInactiveMISOPROSTOL 4% DISPERSION ON HYDROXYPROPYL METHYLCELLULOSE (HPMC)

DMF 175672004

CHINOIN PHARMACEUTCIAL AND CHEMICAL WORKS CO LTDInactiveMISOPROSTOL DISPERSION, HPMC 1%

DMF 208472007

YONSUNG FINE CHEMICALS CO LTDInactiveMISOPROSTOL

DMF 230412009

CHINOIN PHARMACEUTICAL AND CHEMICAL WORKS PRIVATE CO LTDInactiveMISOPROSTOL

DMF 232492009

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 0.1MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jul 2, 2019

No patent or exclusivity listings for this strength.

#002 — 0.2MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jul 2, 2019